FDA Delays Decision on Approval of Elagolix for Endometriosis-Associated Pain
News
The U.S. Food and Drug Administration has pushed back a decision on a new drug application (NDA) for elagolix in the treatment of endometriosis-associated pain, AbbVie and Neurocrine Biosciences recently announced. The ... Read more